Sermorelin Therapy A growth hormone-releasing peptide supporting lean muscle, recovery, sleep, and energy
GIPR increases insulin secretion during hyperglycemia and stimulates glucagon release during hypoglycemia
The apparent increase in sensitivity to IGF-1 was dependent on a functional IGF-1R since as IGF-1 induced Akt and ERK phosphorylation was markedly attenuated by the treatment with PPP (Figure 4f and 4g)
Additionally, injecting into the abdomen, upper arms, and thighs ensures better comfort when administering the treatment
They showed better effects in improving mouse motor function scores, promoting the repair and regeneration of synapses or dopaminergic neurons (TH+, GDNF, synaptophysin), and inhibiting neuroinflammatory responses (IBA-1, IL-2) compared to liraglutide and DA-JC1, highlighting the advantage of targeting more sites